Navamedic ASA (OSL: NAVA)

Market Cap	485.73M
Revenue (ttm)	525.55M
Net Income (ttm)	19.62M
Shares Out	17.66M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	20.52
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,950
Open	28.30
Previous Close	27.30
Day's Range	26.20 - 28.30
52-Week Range	23.00 - 40.00
Beta	0.38
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About Navamedic ASA

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. The company’s product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic and propioni...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2002
• Employees: 45
• Stock Exchange: Oslo Børs
• Ticker Symbol: NAVA

Financial Performance

In 2023, Navamedic ASA's revenue was 512.00 million, an increase of 33.98% compared to the previous year's 382.14 million. Earnings were 3.30 million, a decrease of -88.77%.